Related Experiment Video
Updated: Nov 5, 2025

07:43
Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
7.1K
Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis
Alexandra C M Van Harten1, Hemali Phatnani2, Serge Przedborski3
1Graduate School of Life and Earth Sciences, University of Amsterdam, Science Park 904, 1090 GE Amsterdam, The Netherlands.
Trends in Neurosciences
|May 19, 2021
Summary
Amyotrophic lateral sclerosis (ALS) involves motor neuron loss. Non-neuronal cells, especially astrocytes, significantly contribute to ALS pathogenesis, offering new therapeutic targets.
Area of Science:
- Neuroscience
- Cell Biology
- Neurology
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by motor neuron loss in the central nervous system (CNS).
- Despite extensive research, the exact mechanisms driving ALS pathogenesis remain incompletely understood.
- Emerging evidence highlights the critical role of non-neuronal cells in disease progression.
Purpose of the Study:
- To review the contribution of non-cell-autonomous mechanisms to ALS pathogenesis.
- To emphasize the role of glial cells, particularly astrocytes, in motor neuron degeneration.
- To explore potential therapeutic strategies targeting non-neuronal cells in ALS.
Main Methods:
- Review of existing literature on ALS pathobiology.
- Analysis of studies investigating glial cell function in ALS models.
- Focus on astrocyte-motor neuron interactions in the context of ALS.
Main Results:
- Non-neuronal cells, including astrocytes, are increasingly recognized as active participants in ALS.
- Glial cells can exert both detrimental and potentially protective effects on motor neurons in ALS.
- Astrocytes play a multifaceted role in the neuroinflammatory and neurodegenerative processes observed in ALS.
Conclusions:
- Non-cell-autonomous processes, driven by glial cells like astrocytes, are integral to ALS pathogenesis.
- Understanding these interactions is crucial for developing effective disease-modifying therapies for ALS.
- Targeting glial cell dysfunction presents a promising avenue for future ALS treatments.
Keywords:
amyotrophic lateral sclerosisastrocytesmicrogliamotor neuronsneurodegenerationneuroinflammationnon-cell autonomousMore Related Videos
Related Concept Videos
Amyloid Fibrils
11.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.0K
Parkinson's Disease: Overview
1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Cross-bridge Cycle
120.0K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
120.0K
Lysosomal Hydrolases
4.1K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.1K
Delivery Pathways to the Lysosome
8.3K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.3K
Autophagy
5.1K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.1K

